Your health and safety is always our top priority. Call your physician if you think you have the coronavirus or call 877-9NOVANT if you don’t have one. Learn more »

Welcome to Novant Health GO

Coronavirus clinical trials

Home Services Clinical research Coronavirus clinical trials

Clinical trials and COVID-19

Since the outbreak of the SARS-CoV-2 virus launched a pandemic in early 2020, pharmaceutical companies have been working hard to develop safe and effective treatments for the disease known as COVID-19 and related conditions. A number of drugs approved for other indications, for example, are being studied to see if they show promise in reducing mortality or improving outcomes for those affected by COVID-19. Other novel agents and therapies are being studied to reduce symptoms of COVID-19, reduce viral load, or reduce the need for ventilator support. At the same time, the pharmaceutical industry is partnering with healthcare systems across the globe to develop better diagnostic tools and even artificial intelligence (AI) algorithms to more efficiently and accurately diagnose and even predict those at risk of coronavirus infection. To better protect our families and communities, pharma companies continue to work on safe and efficacious vaccines to prevent SARS-CoV-2 infections.

The U.S. Food and Drug Administration and other federal agencies that regulate clinical research have adapted processes to facilitate these and other efforts to control the pandemic.

Novant Health's investigators, clinical research teams and pharmacists constantly review the needs of our community based on emerging COVID-19 data. Armed with data from our predictive analytics teams, system leaders, federal/state/local agencies and the pharmaceutical industry, we are well-positioned to activate appropriate clinical trials for the communities we serve. We are committed to accomplishing this with a keen focus on ethics, safety, quality, compliance and stewardship.

Novant Health's teams are able to respond quickly to ensure our providers and patients have clinical trial options available when and where needed. The clinical trial landscape is very dynamic, with COVID-19 trials opening (and closing) fairly rapidly. If you or a loved one is facing a COVID-19 diagnosis, we encourage you to reach out to your care team to inquire about clinical trial options that may be available to you locally.

Please continue to follow state and federal guidelines to prevent infection. While clinical trials are an important step in combating the spread of the coronavirus, social distancing and preventive measures such as masking and handwashing remain vitally important.